everlinQ Endovascular Access System Enhancements (EASE) Study

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 27, 2015

Primary Completion Date

June 19, 2017

Study Completion Date

June 19, 2017

Conditions
Chronic Kidney Diseases
Interventions
DEVICE

everlinQ endoAVF System

All Listed Sponsors
lead

TVA Medical Inc.

INDUSTRY

NCT03708770 - everlinQ Endovascular Access System Enhancements (EASE) Study | Biotech Hunter | Biotech Hunter